Product Description
Benzyl alcohol is an aromatic alcohol that consists of benzene bearing a single hydroxymethyl substituent. It has a role as a solvent, a metabolite, an antioxidant and a fragrance. Benzyl alcohol is a Pediculicide. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Benzyl-Alcohol)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical, Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Austria | Bangladesh | Brazil | Chile | Colombia | Egypt | France | Hong Kong | India | Ireland | Malta | New Zealand | Pakistan | South Africa | Taiwan | Turkey | United Arab Emirates | United Kingdom | United States | Venezuela
Approved Indications: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
04/23/2026 |
News Article |
NEURELIS HELPS SUPPORT NATIONAL NETWORK OF EPILEPSY AWARENESS AND SUPPORT AT FIRST EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT WALT DISNEY WORLD |
|
04/16/2026 |
News Article |
NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING |
|
03/16/2026 |
News Article |
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial |
|
02/05/2026 |
News Article |
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit |